- Home
- LONA vs PCM Comparison
LONA vs PCM Comparison
Compare LONA & PCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LONA | PCM |
|---|---|---|
| Founded | 2011 | 1993 |
| Country | United States | United States |
| Employees | 19 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.4M | 82.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LONA | PCM |
|---|---|---|
| Price | $9.29 | $5.68 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | 36.3K | ★ 42.9K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.68% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.21 | $5.52 |
| 52 Week High | $14.21 | $6.76 |
Technical Indicators
Market Signals| Indicator | LONA | PCM |
|---|---|---|
| Relative Strength Index (RSI) | 47.68 | 46.94 |
| Support Level | $8.10 | $5.65 |
| Resistance Level | $9.88 | $6.15 |
| Average True Range (ATR) | 1.01 | 0.08 |
| MACD | -0.11 | -0.00 |
| Stochastic Oscillator | 33.79 | 27.74 |
Price Performance
Historical ComparisonAbout LONA LeonaBio Inc. Common Stock
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.
About PCM PCM Fund Inc.
Pcm Fund Inc is a closed-end investment management company. Its investment objective is to seek current income as a primary focus and also capital appreciation. The Fund invests in agency-guaranteed mortgage-backed securities, private-label mortgage-backed securities, high-yield corporate debt securities, and commercial mortgage-backed securities.